Trilogy Capital’s Alerian MLP ETF AMLP Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLP
AIM
Trilogy Capital's AMLP Position: Q2 2026 in Review
Trilogy Capital increased its Alerian MLP ETF (AMLP) stake by 0.64% in Q2 2026, buying an estimated $4.83K and bringing the position to 14,532 shares worth $753K. The position accounts for 0.03% of the portfolio, ranked #228.
Trilogy Capital first reported a position in AMLP in Q1 2018 and has held it in 10 quarters since. The position peaked at $866K in Q1 2025. 807 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.
- Trilogy Capital held 14,532 shares of Alerian MLP ETF worth $753K as of Q2 2026.
- Trilogy Capital bought 92 Alerian MLP ETF shares in Q2 2026, an estimated $4.83K.
- Alerian MLP ETF made up 0.03% of Trilogy Capital's portfolio in Q2 2026, its #228 holding.
- Trilogy Capital first reported a position in Alerian MLP ETF in Q1 2018 and has held it in 10 quarters since.
- Trilogy Capital's Alerian MLP ETF position peaked at $866K in Q1 2025.
- 807 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.